The European Commission has approved Kimberly Clark’s acquisition of Kenvue, the maker of Tylenol, subject to conditions designed to address competition concerns. The...
ByBuba Malgwi NabeelahOctober 13, 2026Kimberly-Clark has offered concessions to address European Union antitrust concerns over its proposed acquisition of consumer healthcare company Kenvue, as the $40 billion...
ByBenson T. DanielSeptember 23, 2026Excepteur sint occaecat cupidatat non proident